US Stock MarketDetailed Quotes

ELVN Enliven Therapeutics

Watchlist
  • 27.650
  • +0.020+0.07%
Close Nov 4 16:00 ET
  • 27.650
  • 0.0000.00%
Post 16:00 ET
1.31BMarket Cap-16921P/E (TTM)

Enliven Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Enliven Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Enliven Therapeutics Earnings Reports

  • Enliven Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 04:19

  • Enliven Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 15 04:23

  • Enliven Therapeutics | 10-K: Annual report

    Mar 15 04:22

  • Enliven Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 10, 2023 05:15

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data